Literature DB >> 16360836

Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response.

Martin B A Heemskerk1, Dave L Roelen, Marlies K A Dankers, Jon J van Rood, Frans H J Claas, Ilias I N Doxiadis, Machteld Oudshoorn.   

Abstract

CD8+ T cell-mediated alloreactivity is generally believed to involve recognition of the alpha1/alpha2 domains of donor-type class I MHC molecules as well as the peptides they bind. Using the CTLp assay outcome as a parameter for the induction of alloreactivity, we have retrospectively surveyed 80 haematopoietic stem cell donor/patient pairs that feature a range of allelic differences at single HLA-A, -B, and -C loci in an attempt to probe the predictive value of such mismatches. In contrast to the expectation that greater degree of allelic disparity would lead to more alloreactivity, we found that in a substantial number of cases, class I MHC molecules with numerous sequence differences did not elicit an allogeneic CTL response. We propose that in generating a T cell repertoire with a sufficiently narrow responsive for self-MHC, positive thymic selection limits the capacity to recognize allogeneic MHC molecules whose structure and sequence have diverged extensively. These findings are important for donor and patient MHC matching strategies and our understanding of T cell-MHC interaction after haematopoietic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360836     DOI: 10.1016/j.humimm.2005.06.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  19 in total

Review 1.  CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.

Authors:  Tamara Tilburgs; Jack L Strominger
Journal:  Am J Reprod Immunol       Date:  2013-02-23       Impact factor: 3.886

2.  NLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.

Authors:  Tamara Tilburgs; Torsten B Meissner; Leonardo M R Ferreira; Arend Mulder; Kiran Musunuru; Junqiang Ye; Jack L Strominger
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

Review 3.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

4.  Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.

Authors:  V Kosmoliaptsis; M M Jöris; D H Mallon; A C Lankester; P A von dem Borne; J Kuball; M Bierings; J J Cornelissen; M E Groenendijk-Sijnke; B van der Holt; J A Bradley; M Oudshoorn; J J van Rood; C J Taylor; F H J Claas
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

5.  Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.

Authors:  Stephen Spellman; John Klein; Michael Haagenson; Medhat Askar; Lee Ann Baxter-Lowe; Jun He; Susan Hsu; Rainer Blasczyk; Carolyn Hurley
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

6.  Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.

Authors:  Alexis Morice; Béatrice Charreau; Bérangère Neveu; Sophie Brouard; Jean-Paul Soulillou; Marc Bonneville; Elisabeth Houssaint; Nicolas Degauque
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

7.  HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.

Authors:  Lee Ann Baxter-Lowe; Martin Maiers; Stephen R Spellman; Michael D Haagenson; Tao Wang; Marcelo Fernandez-Vina; Steven G E Marsh; Mary Horowitz; Carolyn Katovich Hurley
Journal:  Biol Blood Marrow Transplant       Date:  2009-08       Impact factor: 5.742

Review 8.  Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

Authors:  Effie W Petersdorf
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

9.  In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.

Authors:  Esteban Arrieta-Bolaños; Pietro Crivello; Bronwen E Shaw; Kwang Woo Ahn; Hai-Lin Wang; Michael R Verneris; Katharine C Hsu; Joseph Pidala; Stephanie J Lee; Katharina Fleischhauer; Stephen R Spellman
Journal:  Blood Adv       Date:  2018-07-24

10.  Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.

Authors:  D L Roelen; V A L Huurman; R Hilbrands; P Gillard; G Duinkerken; P W M van der Meer-Prins; M F J Versteeg-van der Voort Maarschalk; C Mathieu; B Keymeulen; D G Pipeleers; B O Roep; F H J Claas
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.